Detalles de la búsqueda
1.
Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study).
Diabetes Obes Metab
; 26(3): 961-970, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073422
2.
Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion assessed using continuous glucose monitoring: A prospective observational study.
Diabetes Obes Metab
; 25(7): 1883-1889, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906821
3.
Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study).
Diabetes Obes Metab
; 25(6): 1503-1511, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36722623
4.
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
Pituitary
; 26(5): 597-610, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37642928
5.
Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.
Diabetes Obes Metab
; 24(3): 391-401, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704329
6.
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
Pituitary
; 25(2): 321-327, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35088194
7.
Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?
Endocr J
; 69(5): 495-509, 2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34819409
8.
Severe infection including disseminated herpes zoster triggered by subclinical Cushing's disease: a case report.
BMC Endocr Disord
; 21(1): 84, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906651
9.
Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia.
Endocr J
; 68(4): 477-484, 2021 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33361650
10.
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Diabetes Obes Metab
; 22(3): 458-462, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31486230
11.
Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial.
Diabetes Obes Metab
; 21(3): 710-714, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30311367
12.
Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study.
Endocr J
; 65(2): 141-150, 2018 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29093280
13.
Effects of 50 mg vildagliptin twice daily vs. 50 mg sitagliptin once daily on blood glucose fluctuations evaluated by long-term self-monitoring of blood glucose.
Endocr J
; 64(4): 417-424, 2017 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28260702
14.
Factors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism.
Endocr J
; 64(4): 387-392, 2017 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28260701
15.
Comparative effects of vildagliptin and sitagliptin determined by continuous glucose monitoring in patients with type 2 diabetes mellitus.
Endocr J
; 63(8): 747-53, 2016 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27321385
16.
Improvement of ß-Cell Function After Switching From DPP-4 Inhibitors to Oral Semaglutide: SWITCH-SEMA2 Post Hoc Analysis.
J Clin Endocrinol Metab
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38695547
17.
Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease.
Diabetes Metab J
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38419467
18.
The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery.
J Stroke Cerebrovasc Dis
; 22(7): 910-8, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23273713
19.
Lipid Droplet Protein PLIN1 Regulates Inflammatory Polarity in Human Macrophages and is Involved in Atherosclerotic Plaque Development by Promoting Stable Lipid Storage.
J Atheroscler Thromb
; 30(2): 170-181, 2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35662076
20.
Effect of Switching to Once-Weekly Semaglutide on Non-Alcoholic Fatty Liver Disease: The SWITCH-SEMA 1 Subanalysis.
Pharmaceutics
; 15(8)2023 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37631377